NextFin News - The clinical encounter is undergoing its most significant structural shift since the introduction of the electronic health record (EHR), as ambient artificial intelligence begins to replace the keyboard as the primary interface between doctor and patient. According to a report from Menlo Ventures, AI spending in the healthcare sector reached $1.4 billion in 2025, nearly tripling the previous year’s total, with adoption rates in the industry now moving 2.2 times faster than the broader economy.
Dr. Keith Roach, a prominent internist at Weill Cornell Medicine known for his long-standing focus on patient-centered primary care, recently highlighted this transition through the lens of patient feedback. In a column published on April 2, 2026, Roach noted that patients are increasingly reporting a "more personal" experience when their physicians utilize AI scribes. The technology allows doctors to maintain eye contact and engage in fluid conversation rather than being tethered to a computer screen to document the visit in real-time.
The shift is driven by a desperate need to mitigate physician burnout, which has reached critical levels across the U.S. healthcare system. By automating the administrative burden of after-visit summaries and EHR data entry, ambient AI tools—which listen to and transcribe clinical conversations—aim to return "the gift of time" to practitioners. However, Roach’s observations come with a caveat shared by many in the medical community: there is a persistent fear that the efficiency gains provided by AI will be captured by hospital administrators to increase daily patient quotas rather than improving the quality of care.
Market data supports the rapid scaling of these tools. The U.S. AI medical scribing market, valued at approximately $397 million in 2024, is projected to surge to nearly $3 billion by 2033, according to Grand View Research. This growth is characterized by a fierce competition between agile startups, which currently capture 85% of generative AI spend in healthcare, and incumbent EHR giants like Epic and Oracle Health, which are racing to integrate native AI scribing capabilities into their existing platforms.
Despite the optimism, the transition is not without friction. While patients like those cited by Roach appreciate the renewed focus, some medical professionals remain skeptical of the accuracy and "hallucination" risks inherent in large language models. There is also a lack of industry-wide consensus on the long-term impact on clinical outcomes. While the technology excels at capturing dialogue, it cannot yet replace the nuanced clinical judgment required to interpret what a patient does not say—the subtle physical cues and emotional subtext that define high-level diagnostic work.
The financial implications are equally complex. Bessemer Venture Partners identifies a new category of "AI-services-as-software" companies that deliver human-quality documentation with software-level margins exceeding 70%. As these tools become standard, the debate will likely shift from whether they should be used to who owns the resulting data and how it influences reimbursement codes. For now, the primary victory for the medical profession is the simple act of a doctor looking a patient in the eye again.
Explore more exclusive insights at nextfin.ai.
